John Toubia

机构：South Australia Pathology, University of South Australia, Australian Cancer Research Foundation, Institut thématique Génétique, génomique et bioinformatique, Centre for Cancer Biology, Adelaide University · ORCID：0000-0002-5135-6504

发表论文 142 篇 · 总被引 4294 次 · h-index 24

代表论文

• Nuclear export of circular RNA (2024 · Nature · 被引 113)
• Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations (2025 · Blood · 被引 11)
• Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease (2024 · Journal of Allergy and Clinical Immunology · 被引 8)
• Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas (2024 · The Journal of Clinical Endocrinology & Metabolism · 被引 8)
• Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry (2025 · Molecular Oncology · 被引 4)
• Neural crest cell-derived DKK1 and NEDD4 modulate Wnt signalling in the second heart field to orchestrate outflow tract development (2026 · Nature Communications · 被引 2)